Education in Psychodermatology: Herpes labialis and genitalis

An open-label study evaluated the safety (n = 53) and pharmacokinetics (n = 8) of single-dose therapy with 1500 mg famciclovir (prodrug of penciclovir) for recurrent herpes labialis in adolescents. Mean Cmax, mean AUC0-∞, and clearance for penciclovir were 9.37 μg/mL, 31.8 μg · h/mL, and 38.2 L/h, respectively, and within the range extrapolated from data in adults. Adverse events were generally mild and transient.

show abstract

Herpes Labialis and Oral Candidiasis in HIV-infected intravenous drug users with poor hematologic status

Sufiawati

Sasanti

2008

Padjadjaran J Dent

View full text Add to dashboard Cite

Hematologic abnormalities are common in HIV-infected patient, particularly in individuals with more advanced HIV disease. Hematologic abnormalities and their association with HIV-associated oral lesions had been reported. Intravenous drug use has been associated with increased oral lesions too. We reported a case of oral lesions in a 24 years old man HIV-infected intravenous drug users. Poor hematologic status is a risk factor of Oral Candidiasis in HIV-infected person with clinical features appear generally. But clinical feature of Herpes Labialis is not usually because his poor hematologic status. It's concluded that poor hematologic status and transmission of HIV through contaminated needlestick are the high risk factors of oral lesions and appear not usually clinical features in ODHA. Correction of these hematologic abnormalities and appropiately management of oral lesions can minimize the severity and to increase the better quality of life patient.

show abstract

Education in Psychodermatology: Herpes labialis and genitalis

Cited by 3 publications

References 32 publications

Dermatologische Problemzonen

Dermatologische Problemzonen

Safety and Pharmacokinetics of a Single 1500-mg Dose of Famciclovir in Adolescents With Recurrent Herpes Labialis

Herpes Labialis and Oral Candidiasis in HIV-infected intravenous drug users with poor hematologic status

Contact Info

Product

Resources

About